JPRN-UMIN000004336已完成未知
Safety and efficacy of cidofovir for adenovirus infection - Safety and efficacy of cidofovir for adenovirus infection
Hematology, Osaka City University, Graduate School of Meicine0 个研究点目标入组 21 人开始时间: 2010年10月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects who meet any of the following criteria are not eligible. 1) Positive for anti-HIV antibody 2) Positive for hepatitis B surface antigen or HBV-DNA 3) Positive for anti-HCV antibody 4) Creatinine clearance lower than 0.1ml/min/kg calculated by the Cockcroft-Gault formula 5) Patients who have coexisting sinusoidal obstruction syndrome 6) Known hypersensitivity to cidofovir 7) Known hypersensitivity to probenecid 8) Patients who are ineligible for this study as judged by the investigator
研究者
相似试验
已完成
不适用
Efficacy and safety of cidofovir for recurrent respiratory papillomatosis (3)recurrent respiratory papillomatosisJPRN-UMIN000020348Kanazawa University1
已完成
不适用
Efficacy and safety of cidofovir for recurrent respiratory papillomatosis (2)recurrent respiratory papillomatosisJPRN-UMIN000020343Kanazawa University2
已完成
不适用
Efficacy and safety of cidofovir for recurrent respiratory papillomatosis (1)recurrent respiratory papillomatosisJPRN-UMIN000020342Kanazawa University2
招募中
不适用
Safety and Immunogenicity of adenovirus vector COVID-19 vaccines following with additional dose of mRNA COVID-19 vaccines for cancer patients.COVID19 Vaccine efficacy in oncologic patient.viral vector vaccine , mRAN vaccinecancer patientsafety and immunogenicityTCTR20220112004Quality Improvement fund, King chulalongkorn Memorial Hospital,The Thai Red Cross Society400
招募中
不适用
Safety and Immunogenicity of adenovirus vector COVID-19 vaccines for radiotherapy patients in ThailandWhat are the immunization and safety effects of the COVID-19 adenovirus vector Astrazenaca vaccine in irradiated patients in Thailand?radiation, covid-19, vaccineTCTR20210921002King Chulalongkorn Memorial Hospital120